Drugs / Non-adjuvanted Trivalent Influenza Vaccine
Non-adjuvanted Trivalent Influenza Vaccine
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01964989 Comparator | Nov 2013 → Oct 2015 | influenza | Seqirus | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Non-adjuvanted Trivalent Influenza Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01964989 ↗ |
| Known as | IIV3 | “non-adjuvanted inactivated influenza vaccine (ie, trivalent inactivated influenza vaccine [IIV3] or quadrivalent inactivated influenza vaccine [IIV4])” PMID 29631857 ↗ Apr 2018 |
| Known as | TIV | “Non-adjuvanted Trivalent Influenza Vaccine (TIV) / Quadrivalent Influenza Vaccine (QIV)” NCT01964989 ↗ |
| Modality | Vaccine | “non-adjuvanted inactivated influenza vaccine (ie, trivalent inactivated influenza vaccine [IIV3] or quadrivalent inactivated influenza vaccine [IIV4])” PMID 29631857 ↗ Apr 2018 |
| Route | Intramuscular | “All vaccinations were administered intramuscularly” PMID 29631857 ↗ Apr 2018 |